Related Experiment Video
Updated: Jan 10, 2026
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Association of Helicobacter pylori with Gallbladder, Pancreatic, and Colorectal Malignancies: A Prospective
Anuradha Dnyanmote1, Vedanth Tirmanwar
1Department of General Surgery, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.
Background:
Helicobacter pylori is a globally prevalent pathogen implicated in multiple gastrointestinal malignancies. While its role in gastric cancer is well established, its association with extragastric malignancies such as gallbladder carcinoma (GBC), pancreatic carcinoma (PC), and colorectal carcinoma (CRC) remains contentious.
Objective:
To evaluate the prevalence of H. pylori in gallbladder, pancreatic, and colorectal malignancies and to assess its potential associations.
Materials And Methods:
This prospective observational study was conducted between January 2023 and March 2025 at a tertiary hospital in India. Seventy-six histologically confirmed cases of GBC ( n = 42), CRC ( n = 24), and PC ( n = 10) underwent immunohistochemistry testing for H. pylori . The data were analyzed using SPSS v26.0; P < 0.05 was considered statistically significant.
Results:
The overall prevalence of H. pylori was 22.4%. It was detected in 26.2% of GBC, 8.3% of CRC, and 40% of PC cases. However, no statistically significant association was found between H. pylori presence and any malignancy type ( P > 0.05).
Conclusion:
Although H. pylori was detected in a subset of GBC, PC, and CRC cases, the association was not statistically significant. Further multicenter studies with larger cohorts are necessary to explore potential etiological roles.
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...